These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10026713)

  • 1. Clinically significant drug interactions.
    Johnson MD; Newkirk G; White JR
    Postgrad Med; 1999 Feb; 105(2):193-5, 200, 205-6 passim. PubMed ID: 10026713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update: clinically significant cytochrome P-450 drug interactions.
    Michalets EL
    Pharmacotherapy; 1998; 18(1):84-112. PubMed ID: 9469685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding cooperativity in human p450 mediated drug-drug interactions.
    Sligar SG; Denisov IG
    Drug Metab Rev; 2007; 39(2-3):567-79. PubMed ID: 17786639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug metabolism and drug interactions in the elderly.
    Herrlinger C; Klotz U
    Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):897-918. PubMed ID: 11866484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.
    Touw DJ
    Drug Metabol Drug Interact; 1997; 14(2):55-82. PubMed ID: 9893738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why bother about cytochrome P450 enzymes?
    Drug Ther Bull; 2000 Dec; 38(12):93-5. PubMed ID: 11221185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic basis of drug interactions in the intensive care unit.
    Streetman DS
    Crit Care Nurs Q; 2000 Feb; 22(4):1-13. PubMed ID: 11852961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important drug interactions and reactions in dermatology.
    Aria N; Kauffman CL
    Dermatol Clin; 2003 Jan; 21(1):207-15, ix. PubMed ID: 12622282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytochrome p-450 drug metabolizing enzyme system: an overview of potential clinically important drug interactions.
    Wroblewski B; Glenn MB
    J Head Trauma Rehabil; 2002 Dec; 17(6):571-4. PubMed ID: 12802247
    [No Abstract]   [Full Text] [Related]  

  • 11. Current knowledge of the cytochrome P-450 isozyme system: can we predict clinically important drug interactions?
    McKindley DS; Dufresne RL
    Med Health R I; 1998 Feb; 81(2):38-42. PubMed ID: 9505063
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytochrome P-450 isoenzymes as predictors of drug interactions].
    Pelkonen O
    Duodecim; 1994; 110(17):1575-9. PubMed ID: 7497987
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinically relevant adverse drug interactions].
    Martin-Facklam M; Haefeli WE
    Ther Umsch; 2000 Sep; 57(9):579-83. PubMed ID: 11036439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.
    Muruganandan S; Sinal CJ
    Clin Pharmacol Ther; 2008 Jun; 83(6):818-28. PubMed ID: 18388875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-associated disease: cytochrome P450 interactions.
    Mann HJ
    Crit Care Clin; 2006 Apr; 22(2):329-45, vii. PubMed ID: 16678003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics.
    Morgan ET
    Clin Pharmacol Ther; 2009 Apr; 85(4):434-8. PubMed ID: 19212314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of metabolic drug-drug interactions: a descriptive and critical commentary.
    Li AP
    Curr Protoc Toxicol; 2007; Chapter 4():Unit 4.25. PubMed ID: 23045147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes.
    Zientek MA; Youdim K
    Drug Metab Dispos; 2015 Jan; 43(1):163-81. PubMed ID: 25297949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast regulation of cytochrome P450 activities by phosphorylation and consequences for drug metabolism and toxicity.
    Oesch-Bartlomowicz B; Oesch F
    Biol Chem; 2002 Oct; 383(10):1587-92. PubMed ID: 12452435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.